As of Sep 29
| -0.30 / -0.18%|
The 1 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 225.00, with a high estimate of 225.00 and a low estimate of 225.00. The median estimate represents a +38.92% increase from the last price of 161.96.
The current consensus among 1 polled investment analysts is to Buy stock in Bio Rad Laboratories Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.